众生药业:构建肿瘤和糖尿病团队战略规划中的一大步
众生药业:构建肿瘤和糖尿病团队战略规划中的一大步: 点评:引进肿瘤和糖尿病创新药物研发与产业化团队，与公司整体的经营战略一致。公司目前主要的在研产品都是围绕眼科和老年性疾病展开。包括健行颗粒、WCH-016项目、DXZ923纳米制剂项目等。新团队的 ...
A brutal elimination round is reshaping the world's biggest market for electric cars
Chinese EV makers showing off their newest models at Auto China , which kicks off in Beijing have enjoyed generous support from the ... View article...